Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.9 |
mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |